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Abstract
Background: The values obtained when the fraction of exhaled nitric oxide (FeNO)
is measured are affected by several factors that are specific to the individual patient,
making interpretation difficult, especially in the initial assessment of patients with
respiratory symptoms.
Methods: Systematic review of studies on FeNO reference values and individual-
specific factors that influence them.
Results: From 3739 references, 15 studies were included. Four studies included
children and adolescents. In nine studies, samples were selected from the general
population. Most studies reported objective measures for atopy (nine studies), but
not for smoking status (one). Significant determinants of FeNO values reported
were age and height (seven studies), atopy (six), smoking (four), weight (four), sex
(three) and race (three). Additional factors were included in eight studies. R2 was
reported in only five studies. The logarithmic transformation of FeNO was inad-
equately described in seven studies.
Conclusion: There are several equations for FeNO reference values that may be
used in clinical practice, although the factors they include and the statistical
methods they use vary considerably. We recommend the development of standard
methods for the evaluation of normal FeNO data and that reference equations
should be formulated based on a predetermined physiological model.
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Introduction
The measurement of the fraction of exhaled nitric
oxide (FeNO) is now recognized as an accurate, repro-
ducible and completely non-invasive diagnostic test for
airway disease (1).
FeNO correlates significantly with bronchial hyper-
responsiveness as measured by indirect or direct
methods (2) and with the degree of immunoglobulin E
(IgE) sensitization (3–5). Furthermore, FeNO is asso-
ciated with eosinophilia in patients with asthma, e.g. as
measured in sputum (6) and bronchial biopsies (7, 8).
FeNO decreases quickly after the start of anti-
inflammatory therapy when airway inflammation is
suppressed and increases after withdrawal of therapy
(9–11).
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The measurement of FeNO has been used in many
settings, but one of the most studied clinical applica-
tion is the initial assessment of patients with respira-
tory symptoms (12). However, FeNO values can be
difficult to interpret, as they are strongly influenced by
several intra-individual factors, including age, height,
weight, sex, atopy and smoking habits (13). This is
one of many problems with diagnostic tests, as
recently discussed (14): it is difficult to define ‘nor-
mality’ in a given assessment (15, 16). Moreover, the
numeric value of a diagnostic test can be presented in
several forms: the absolute value, the per cent of pre-
dicted of a reference value and z-scores. Absolute
values are rarely used in lung function tests; however,
they are presently used in the interpretation of FeNO.
It has been proposed that a ‘personal best’ value for
FeNO might be used (17). This is a strong approach if
the objective is to monitor FeNO. However, for the
initial assessment of FeNO in a patient, this method
cannot be used. Furthermore, the personal best values
were shown to be close to published reference values
(17). Thus, the use of equations to calculate reference
values may be a practical and clinically useful
approach.
The aim of this study is to conduct a systematic
review of the published literature on the analysis of
reference/normative values and on the effects of indi-
vidual factors (age, sex, height, weight, smoking status
and atopy) on FeNO values in healthy individuals.
Material and methods
Eligibility criteria
The inclusion criteria were (i) study sample includes
healthy individuals, with no history of asthma, rhinitis
or other respiratory or allergic diseases; (ii) measure-
ment of FeNO should be made using the online
method, with a constant exhalation flow rate of
50 5 mL/s, according to international recommen-
dations (18); (iii) factors included are one or more of
these: age, gender, height, weight, smoking status or
atopy (additional factors in the study analysis were
allowed and were described); (iv) NO analyser brand
and model is specified; and (v) statistical analysis
includes a simple or multivariate linear regression
in which FeNO is the or one of the dependent
variable(s).
Exclusion criteria are (i) animal or in vitro testing;
(ii) less than 50 healthy subjects assessed with respect to
FeNO values; and (iii) studies about other factors such
as exercise, environmental exposures and concomitant
non-respiratory, genetic or immunologic diseases.
Search strategy
Studies were identified by searching PubMed, SCOPUS
and ISI Web of Knowledge from January 1990 to
December 2010. The reference list from published
international guidelines for the measurement of
exhaled nitric oxide (18) was also included. Our search
was limited to English-language articles and included
unpublished studies. Abstracts, letters, reviews and
editorials without original data were not included.
The final search included the terms: exhaled nitric
oxide, feno, eno, reference values, normative values,
normal values, healthy individuals, age, gender, height,
weight (or combined as BMI), smoking status and atopy.
The query used in Medline was: [(smok* OR ciga-
rette OR tobacco) OR (age OR age factors) OR (weight
OR body weight) OR (height OR body height) OR
(gender OR sex)] AND (exhaled nitric oxide OR eNO
OR FENO) AND (healthy individuals OR (reference
values OR normal values OR normative values) OR
effect). Efforts were made to gather all full-text papers,
including contact with authors.
Study selection
Study selection had two phases. The first phase was
analysis of the title and abstract of the studies found in
the databases search. Two independent reviewers (TJ
and JAF) classified all studies as included or not.When
the abstract of the study did not provide sufficient
information to decide on inclusion or exclusion, the
study was allowed to the next phase.
The second phase was the analysis of the full-text
paper of the study. Again, two reviewers (TJ and JAF)
independently classified the study as included or not.
Unweighted Kappa was calculated.
Data extraction
The variables extracted from the included studies were:
sampled population and country of origin,number and
age of participants on whommeasurements of exhaled
nitric oxide were performed, smoking habits and atopy
assessment methodology and exhaled nitric oxide ana-
lyser. In addition, the statistical regression model used
in the study, dependent variable(s), intercept values,
significant factors and the R2 value were noted.
Results
We screened 3739 references [1367 in PubMed, 1243
in Scopus, 1029 in ISI and 20 from the American
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Thoracic Society / European Respiratory Society (ATS/
ERS) guidelines] fromwhich were retrieved 207 poten-
tially eligible full articles. Unweighted Kappa was 0.83
[95% confidence interval (CI) 0.74–0.92]. Review flow
chart is shown in Fig. 1.
Fifteen studies were included.
The characteristics of the included studies are shown
in Table 1.
Four studies (26%) were performed on children and
adolescents, and in nine studies (60%), the samples
were selected from the general population. The median
(min–max) number of participants in each study was
524 (114–2200). Atopy was assessed using skin prick
tests in four studies, questionnaires in three, total IgE
in three studies and specific IgE in two studies. Only
one study reported objective measurement of smoking
status (serum cotinine levels) (19).Methods for assess-
ment of atopy and smoking status were not reported in
one study (20).
The detailed analysis of the factors and statistical
methods of the included studies is shown in Table 2.
In eight studies, the dependent variable (FeNO)
was logarithmically transformed: natural logarithm
(n = 3), decadic logarithm (n = 1) and unknown loga-
rithmic base (n = 7). The intercept of the models was
reported in nine studies. The R2 value was reported in
five studies.
Age and height were significant factors in seven
studies, atopy in six, smoking in four,weight in four and
sex and race in three studies. Additional factors were
included in eight studies. Asthma diagnosis was the
most frequent factor (n = 4). Other factors were upper
respiratory tract infection (n = 2), forced vital capacity
(n = 2), reporteduse of inhaled corticosteroid, total IgE,
serum eosinophil cationic protein and an interaction
between sex and smoking habits (n = 1 each).
The absolute values of FeNO are presented with
great heterogeneity in the included studies. Data are
presented using several central tendency and disper-
sion measures (mean, geometric mean, median, inter-
quartile range, standard deviation and 95% and 90%
CIs) and in different subgroups (data not shown).
Discussion
This is the first systematic review concerning reference
values for exhaled nitric oxide. Fifteen studies met the
selection criteria, and the factors and statistical models
used to derive reference equations were retrieved. We
have observed great variation in the factors and statis-
tical methods used, which prevents an adequate com-
parison of reference values from different studies.With
current published data, the selection of reference equa-
tions for FeNO is a difficult task for laboratories and
physicians.
Exhaled NO originates primarily in the airway epi-
thelium, produced by inducible NO synthase (13).
Airway NO formation is seen already at birth, and the
basal NO formation seen in healthy subjects is highly
resistant to corticosteroids (21). Because biological
NO formation is a complex and energy-consuming
process, this suggests that airway NO formation is
important in humans and, consequently, should be
under tight biological control under normal circum-
stances. The origin in the airway epithelium indicates
that the total surface area of the airway mucosa will be
an important determinant for exhaled NO. Indeed, the
airway diffusing capacity for NO, which theoretically
should be dependent on the airway mucosal surface
area, has been shown to correlate with anatomic dead
space volume in healthy children (22). Thus, it is
logical that age and height were found to be important
factors when evaluating FeNO values, as seen for
Figure 1. Systematic review flow chart. FENO, fraction of
exhaled nitric oxide.
Jacinto et al. Reference values for exhaled nitric oxide measurement
115The Clinical Respiratory Journal (2013) • ISSN 1752-6981
© 2012 Blackwell Publishing Ltd
Ta
b
le
1.
D
es
cr
ip
tio
n
of
th
e
in
cl
ud
ed
st
ud
ie
s
St
ud
y
C
ou
nt
ry
Po
pu
la
tio
n
N
A
ge
A
to
py
Sm
ok
in
g
A
na
ly
se
r
W
ith
re
fe
re
nc
e
eq
ua
tio
ns
D
re
ss
el
20
08
(2
0)
G
er
m
an
y
Pr
e-
em
pl
oy
m
en
t
pr
ev
en
tiv
e
m
ed
ic
al
ch
ec
k-
up
s
89
7
34
.5

13
.0
‡
C
H
C
H
Si
ev
er
s
N
O
A
28
0
(G
en
er
al
El
ec
tr
ic
C
om
pa
ny
,
Fa
irfi
el
d,
C
on
ne
ct
ic
ut
,
U
.S
.)
H
ab
ib
20
09
(2
1)
Sa
ud
iA
ra
bi
a
M
ed
ic
al
st
ud
en
ts
an
d
ho
sp
ita
lp
er
so
nn
el
13
8
31
.0

12
.2
‡
T
Ig
E
Q
N
O
X
EV
A
40
00
(S
er
es
,
A
ix
-e
n-
Pr
ov
en
ce
,
Fr
an
ce
)
K
ov
es
i2
00
8
(2
3)
C
an
ad
a
C
hi
ld
re
n
fr
om
sc
ho
ol
s
(G
ra
de
4
to
6)
65
7
10
.8
(9
.1
–1
2.
9)
*
Q
Q
Ec
oM
ed
ic
s
C
LD
88
sp
(E
co
M
ed
ic
s,
Sw
itz
er
la
nd
)
K
ov
es
i2
00
8
(2
4)
C
an
ad
a
C
hi
ld
re
n
fr
om
sc
ho
ol
s
(G
ra
de
4
to
6)
11
35
10
.8
(9
.1
–1
2.
7)
*
Q
Q
Ec
oM
ed
ic
s
C
LD
88
sp
Le
ve
sq
ue
20
08
(2
5)
U
ni
te
d
St
at
es
Lo
ca
lu
ni
ve
rs
ity
ca
m
pu
s
89
5
22
.5

4.
5‡
T
Ig
E
SC
Si
ev
er
s
N
O
A
28
0
M
al
m
be
rg
20
06
(2
8)
Fi
nl
an
d
C
hi
ld
re
n
fr
om
lo
ca
lp
rim
ar
y
an
d
se
co
nd
ar
y
sc
ho
ol
s
11
4
11
.6
(6
.9
–1
5.
7)
*
SP
T
Q
N
IO
X
(A
er
oc
rin
e
A
B,
Sw
ed
en
)
O
lin
20
06
(3
0)
Sw
ed
en
G
en
er
al
po
pu
la
tio
n§
22
00
50
.5
§
S
Ig
E
Q
N
IO
X
O
lin
20
07
(3
1)
Sw
ed
en
G
en
er
al
po
pu
la
tio
n§
11
31
50
.3

13
.8
‡
S
Ig
E
Q
N
IO
X
Ta
yl
or
20
07
(3
4)
N
ew
Ze
al
an
d
D
un
ed
in
H
ea
lth
an
d
D
ev
el
op
m
en
t
St
ud
y
C
oh
or
t
89
5
32
¶
SP
T
T
Ig
E
Q
LR
20
00
(L
og
an
Re
se
ar
ch
,
U
K
)
W
ith
ta
bl
es
of
lim
it
va
lu
es
Bu
ch
va
ld
20
05
(1
9)
Th
e
N
et
he
rla
nd
s,
Ita
ly,
U
ni
te
d
St
at
es
C
hi
ld
re
n
fr
om
ki
nd
er
ga
rt
en
s
an
d
sc
ho
ol
s
40
5
4–
17
†
Q
Q
N
IO
X
K
im
20
10
(2
2)
So
ut
h
K
or
ea
H
os
pi
ta
le
m
pl
oy
ee
s
an
d
m
ed
ic
al
st
ud
en
ts
16
6
M
:
33
.2

12
.1
‡
F:
32
.2

7.
9‡
SP
T
Q
Si
ev
er
s
N
O
A
28
0i
Li
u
20
09
(2
6)
Ta
iw
an
Vo
lu
nt
ee
rs
fr
om
a
ge
ne
ra
l
he
al
th
ch
ec
k-
up
24
9
45
.3

12
.2
‡
C
H
Q
Si
ev
er
s
N
O
A
28
0i
M
ae
st
re
lli
20
07
(2
7)
Ita
ly
O
cc
up
at
io
na
lh
ea
lth
cl
in
ic
12
2
40

1.
0
‡
N
R
N
R
N
IO
X
M
at
su
na
ga
20
10
(2
9)
Ja
pa
n
G
en
er
al
po
pu
la
tio
n
24
0
39
.4

13
.6
‡
C
H
C
H
N
IO
X
M
in
o
(A
er
oc
rin
e
A
B,
Sw
ed
en
)
Tr
av
er
s
20
07
(3
5)
N
ew
Ze
al
an
d
G
en
er
al
po
pu
la
tio
n
52
4
56
.2

12
.9
‡
SP
T
C
H
N
IO
X
*M
ed
ia
n
(in
te
rq
ua
rt
ile
ra
ng
e)
.
†R
an
ge
.
‡M
ea
n

st
an
da
rd
de
vi
at
io
n.
§W
ei
gh
te
d
m
ea
n.
¶
A
ll
in
di
vi
du
al
s
ha
ve
32
ye
ar
s
(c
oh
or
t
st
ud
y)
.
N
R,
no
t
re
po
rt
ed
;
Q
,
qu
es
tio
nn
ai
re
;
S
Ig
E,
sp
ec
ifi
c
im
m
un
og
lo
bu
lin
E;
T
Ig
E,
to
ta
li
m
m
un
og
lo
bu
lin
E;
SP
T,
sk
in
pr
ic
k
te
st
s;
C
H
,
cl
in
ic
al
hi
st
or
y;
SC
,
se
ru
m
co
tin
in
e.
Reference values for exhaled nitric oxide measurement Jacinto et al.
116 The Clinical Respiratory Journal (2013) • ISSN 1752-6981
© 2012 Blackwell Publishing Ltd
other lung function parameters, and it is especially
important to take these factors into account when
evaluating FeNO of growing children. Furthermore,
Gelb et al. (23) have recently shown that FeNO and
alveolar NO, but not bronchial NO flux, increase with
age in adults, especially above 60 years. This is sug-
gested to be because of the reduced lung diffusing
capacity for NO (and carbon monoxide) seen in
elderly, leading to less uptake of bronchial NO in the
alveolar tract. Because the effect of age is stronger
below 18 years and above 60 years and the effect of
height is stronger in children, the regression needs to
be nonlinear if the population under study includes all
ages. Some studies have reported conflicting results on
the influence of sex on FeNO values (24, 25). In the 15
included studies, only two had sex as a significant
factor (25, 26). However, FeNO would be expected to
be higher inmen than women, regardless of e.g. height,
because men have a larger anatomic dead space volume
in relation to bodyweight [see Pedroletti et al.(22)].
Few studies included non-Caucasian subjects (19,
27, 28). As the effect of race on FeNO values is far from
established (29), current data are vastly inadequate to
allow conclusions concerning people of other genetic
Table 2. Description of statistical models of the included studies
Study Model
Dependent
variable Factors R2
With reference equations
Dressel 2008 (20) MLR (GLM) Log(FeNO) Height, smoking, asthma,
respiratory tract infection
NR
Habib 2009 (21) SLR and MLR FeNO Bodyweight, BMI NR
Kovesi 2008 (23) NR FeNO Age, Race, FVC
Kovesi 2008 (24) Univariate and MLR FeNO Age, height, atopy, asthma,
healthy
NR
Levesque 2008 (25) Univariate and MLR Log(FeNO) T IgE, Sex, current URI
symptoms, ECP
T IgE: 15%
Sex: 21%
Current URI symptoms:
25%
ECP: 26%
Malmberg 2006 (28) Analysis of covariance
(ANCOVA)
Log10(FeNO) Age, height, weight, BSA Height: 17%
Age: 15%
Weight: 16%
BSA: 16%
Olin 2006 (32) MLR (GLM) Log(FeNO) Age, height, atopy, weight,
smoking, asthma symptoms
in the last month,
medical diagnosis of asthma,
reported use of ICS
NR
Olin 2007 (33) MLR (GLM) FeNO Age, height, atopy 12%
Taylor 2007 (34) SLR and MLR Log(FeNO) Atopy, smoking, sex,
sex*smoker (smoked day
of test), sex*smoker
(not smoked day of test)
33%
With tables of limit values
Buchvald 2005 (19) MLR (backward stepwise) Ln(FeNO) Age NR
Kim 2010 (22) MLR Log(FeNO) Male gender, atopy NR
Liu 2009 (26) MLR Ln(FeNO) Age, FVC NR
Maestrelli 2007 (27) Stepwise regression Ln(FeNO) Weight NR
Matsunaga 2010 (29) Regression tree Log(FeNO) No significant factors NR
Travers 2007 (35) MLR Log(FeNO) Height, atopy, smoking,
sex, asthma
NR
*Multiplication symbol.
Ln, natural logarithm; Log10, decadic logarithm; Log, unknown logarithmic base; FeNO, fraction of exhaled nitric oxide; MLR, multiple linear
regression; GLM, general linear model; SLR, simple linear regression; NR, not reported; T IgE, total immunoglobulin E;.BMI, body mass index;
FVC, forced vital capacity; URI, Upper Respiratory Infection; ECP, eosinophil cationic protein; BSA, Body Surface Area; ICS, inhaled corticosteroid.
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background. There is evidence that race and ethnicity
may play an important role in lung function prediction
(32).
Most of the studies included did not assess atopy and
smoking habits with objective methods. For the defi-
nition of reference values for FeNO, these are essential
variables and their assessment using questionnaire
data is insufficient.
In addition to individual-specific factors, several
behavioural and environmental factors have been
pointed out as influencing FeNO, such as rhinovirus
infections (33), allergen exposure (34, 35), physical
exercise (36, 37), ozone exposure (38, 39) and air pol-
lution (40). In fact, the low percentage of variance
explained by the reported models possibly reveals the
difficulty of determining the effect of different exog-
enous factors and their combination on FeNO. For
example, the effect of atopy cannot easily be captured
in a single factor, because atopy may result in an
increase in FeNO of anywhere between zero and
several hundred parts per billion (ppb) depending on
the degree of IgE sensitization and the level of allergen
exposure. However, this does not rule out the benefit of
adjusting for the more predictive effect of for example
age, height and gender on expected normal FeNO
values.
A source of variation of the reference equations pub-
lished may be the use of different FeNO analysers or
calibration procedures (41), even though all 15 studies
reported that they were following the ATS/ERS FeNO
measurement guidelines (18).
FeNO reference values should be further refined in
the future, perhaps in ways similar to those recently
reviewed by Stanojevic et al. (14) for lung function
measurements. For example, samples with a wider
range of ages and different races or ethnicities, multi-
centre research teams, and the use of standardized tech-
nical and statistical procedures are desirable features
for FeNO reference equation studies.A large US dataset
meeting many of the earlier criteria was recently pub-
lished as part of the National Health and Nutrition
Examination Survey 2007–2008 and 2009–2010 (42).
The definition and future use of specific guidelines
on how to report studies on reference values may con-
tribute to the standardization of reports. Published
FeNO recommendations (18, 43) are helpful in the
standardization of the measurement, but not in the
standardization of how the methods are described.
The interpretation of FeNO currently involves the
use of absolute values reported in ppb, both in clinical
practice and research, although absolute values are
seldom used in respiratory medicine diagnostic tests.
The per cent predicted of the reference value is now a
standard transformation in most lung function labo-
ratories, and z-scores are increasingly suggested (14).
We suggest the use of a similar approach when inter-
preting FeNO values, either by using the per cent pre-
dicted of the reference value or z-scores. Further
research is needed to clarify this proposal. Neverthe-
less, the individual factors taken into consideration will
be an important step to improve the interpretation of
FeNO values. Such factors are easily accessible at the
clinic and incorporating them will require very little
extra effort. Most importantly, if reference equations
are used, clinical cut-offs can be generalized across age
groups and genetic backgrounds.
In conclusion, several reference equations are already
available, albeit mainly for Caucasians. These can be
used in clinical practice, provided that the study char-
acteristics (population, sampling, objective measures)
are taken into consideration when such an equation is
used for the interpretation of a FeNO value. The pub-
lished equations differ considerably in terms of
individual-specific factors that have an effect on FeNO
values, and there is little standardization of the method
description in the studies, both on the statistical and
technical side. We suggest that the methodology and
reporting on normal FeNO values and the correspond-
ing reference equations should be standardized and
that the formulation of reference equations should be
based on a preset physiological model with endog-
enous and stable (at least in the short term) factors
such as sex, age and height. Furthermore, the influence
of exogenous factors should be minimized in the
population under study, for example by using objective
allergy testing and objective markers of exposure to
cigarette smoke.
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